Schäfer-Korting, Monika 1952-
Schäfer-Korting, Monika
Monika Schäfer-Korting
Schäfer, Monika, 1952-
VIAF ID: 64619648 (Personal)
Permalink: http://viaf.org/viaf/64619648
Preferred Forms
- 100 0 _ ‡a Monika Schäfer-Korting
- 200 _ | ‡a Schäfer-Korting ‡b Monika
-
- 100 1 _ ‡a Schäfer-Korting, Monika ‡d 1952-
-
- 100 1 _ ‡a Schäfer-Korting, Monika, ‡d 1952-
- 100 1 _ ‡a Schäfer-Korting, Monika, ‡d 1952-....
-
- 100 1 _ ‡a Schäfer-Korting, Monika
-
-
-
-
- 100 1 _ ‡a Schäfer-Korting, Monika ‡d 1952-
4xx's: Alternate Name Forms (18)
5xx's: Related Names (5)
- 551 _ _ ‡a Berlin ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Freie Universität Berlin ‡b Fachbereich Biologie, Chemie, Pharmazie ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Gießen ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _ ‡a Institut für Pharmazie ‡g Freie Universität, Berlin ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Institut für Pharmazie
Works
Title | Sources |
---|---|
Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin. | |
[Antimycotics] | |
Antitumor effects of guanosine-analog phosphonates identified by molecular modelling | |
Arzneimittelwirkungen : Lehrbuch der Pharmakologie und Toxikologie : mit einführenden Kapiteln in die Anatomie, Physiologie und Pathophysiologie | |
The barrier function of organotypic non-melanoma skin cancer models. | |
The benefit/risk ratio : a handbook for the rational use of potentially hazardous drugs | |
[Bronchial asthma and inflammatory dermatoses. Topical glucocorticoid treatment]. | |
Carriers in the topical treatment of skin disease | |
Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin | |
Characterization of reconstructed human skin containing Langerhans cells to monitor molecular events in skin sensitization. | |
Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake | |
Cytoprotective effects of opioids on irradiated oral epithelial cells | |
Data-based modeling of drug penetration relates human skin barrier function to the interplay of diffusivity and free-energy profiles | |
Different skin thinning potential of equipotent medium-strength glucocorticoids | |
Drug actions : basic principles and therapeutic aspects | |
Drug delivery | |
The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. | |
Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate | |
Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin - assessment by intradermal microdialysis and extraction from the different skin layers | |
Evaluation of anti-inflammatory and atrophogenic effects of glucocorticoids on reconstructed human skin | |
Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells | |
Glucocorticoid receptor interactions with glucocorticoids: evaluation by molecular modeling and functional analysis of glucocorticoid receptor mutants | |
A Highly Photostable Hyperbranched Polyglycerol-Based NIR Fluorescence Nanoplatform for Mitochondria-Specific Cell Imaging | |
Human defensins | |
Human polymerase alpha inhibitors for skin tumors. Part 2. Modeling, synthesis and influence on normal and transformed keratinocytes of new thymidine and purine derivatives | |
Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling | |
In vitro models for human skin disease | |
Increased cutaneous absorption reflects impaired barrier function of reconstructed skin models mimicking keratinisation disorders | |
Increased permeability of reconstructed human epidermis from UVB-irradiated keratinocytes. | |
Influence of massage and occlusion on the ex vivo skin penetration of rigid liposomes and invasomes | |
Influence of nanocarrier type and size on skin delivery of hydrophilic agents | |
Influence of Th2 Cytokines on the Cornified Envelope, Tight Junction Proteins, and ß-Defensins in Filaggrin-Deficient Skin Equivalents. | |
Influences of opioids and nanoparticles on in vitro wound healing models | |
Integrin specificity of the cyclic Arg-Gly-Asp motif and its role in integrin-targeted gene transfer | |
Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes | |
Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone | |
Kompendium farmakologii i toksykologii Mutschlera | |
Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease | |
Lysophosphatidic acid interacts with transforming growth factor-beta signaling to mediate keratinocyte growth arrest and chemotaxis | |
Molecular modelling studies of new potential human DNA polymerase α inhibitors | |
Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation | |
Mutschler Arzneimittelwirkungen kompakt | |
New systemic antifungal drugs: mechanisms of action, drug interactions and side effects | |
Optimierte Arzneimitteltherapie | |
Organotypic models in drug development, 2021: | |
Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans | |
Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment? | |
Perspectives on percutaneous penetration: Silica nanoparticles | |
[Pharmacology at the Free University of Berlin. The presentation of a chair in pharmacology and toxicology at the Free University of Berlin]. | |
Pharmakokinetik oraler Antimykotika | |
Pitfalls in using fluorescence tagging of nanomaterials: tecto-dendrimers in skin tissue as investigated by Cluster-FLIM. | |
Poly[acrylonitrile-co-(N-vinyl pyrrolidone)] nanoparticles - Composition-dependent skin penetration enhancement of a dye probe and biocompatibility. | |
Receptor-selective retinoids for psoriasis: focus on tazarotene | |
SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions | |
Specific uptake mechanisms of well-tolerated thermoresponsive polyglycerol-based nanogels in antigen-presenting cells of the skin | |
Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing | |
Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses | |
Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation | |
Structural aspects of histone H1-DNA complexes and their relation to transfection efficiency. | |
Suitability of skin integrity tests for dermal absorption studies in vitro. | |
SV40-transformed human corneal keratocytes: optimisation of serum-free culture conditions. | |
Synergistic effects of dexamethasone and quinolones on human-derived tendon cells | |
A thermosensitive morphine-containing hydrogel for the treatment of large-scale skin wounds. | |
TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts | |
Topically applied virus-like particles containing HIV-1 Pr55gag protein reach skin antigen-presenting cells after mild skin barrier disruption | |
Use of oral contraceptives in Germany: prevalence, determinants and use-associated health correlates. Results of National Health Surveys from 1984 to 1999 | |
The use of reconstructed human epidermis for skin absorption testing: Results of the validation study |